titanium has been researched along with Leukemia P388 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hesse, B; Köpf, H; Köpf-Maier, P; Wagner, W | 1 |
| Keppler, BK; Schmähl, D | 1 |
2 other study(ies) available for titanium and Leukemia P388
| Article | Year |
|---|---|
Tumor inhibition by metallocenes: activity against leukemias and detection of the systemic effect.
Topics: Animals; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Dose-Response Relationship, Drug; Female; Leukemia L1210; Leukemia P388; Leukemia, Experimental; Mice; Mice, Inbred Strains; Organometallic Compounds; Titanium; Vanadium; Vanadium Compounds | 1981 |
Preclinical evaluation of dichlorobis(1-phenylbutane-1,3-dionato)titanium (IV) and budotitane. Two representatives of the new class of antitumor-active bis-beta-diketonato metal complexes.
Topics: Animals; Antineoplastic Agents; Body Weight; Carcinoma 256, Walker; Chemistry, Pharmaceutical; Cisplatin; Columbidae; Drug Evaluation, Preclinical; Leukemia L1210; Leukemia P388; Male; Mice; Mice, Inbred Strains; Neoplasm Transplantation; Organometallic Compounds; Rats; Sarcoma 180; Titanium | 1986 |